Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.2792 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
420 with CNW — Kentucky Prepares to Implement Medical Cannabis Executive Order
Via Investor Brand Network
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
420 with CNW — Kentucky Prepares to Implement Medical Cannabis Executive Order
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
Research Discovers Bidirectional Link Between Lower-Back Pain, Insomnia
Via Investor Brand Network
420 with CNW — Bipartisan Legislators Call on Biden to Support Cannabis Legalization
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Bipartisan Legislators Call on Biden to Support Cannabis Legalization
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — DOJ Official Explains Upcoming Process to Gain Presidential Marijuana Pardon
Via Investor Brand Network
Topics Cannabis Lawsuit
Exposures Cannabis Criminal Legal
420 with CNW — DOJ Official Explains Upcoming Process to Gain Presidential Marijuana Pardon
Via CannabisNewsWire
Topics Cannabis Lawsuit
Exposures Cannabis Criminal Legal
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Files Updated Life Sciences Presentation
Via Investor Brand Network
Topics Regulatory Compliance
Exposures Legal Regulatory
420 with CNW — Canadian Medical Marijuana Companies Target Patients with Health Cover
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — Canadian Medical Marijuana Companies Target Patients with Health Cover
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — FDA Seeks More Data in Fight Against Delta-8 THC Products
Via Investor Brand Network
Topics Cannabis Derivatives
Exposures Cannabis Derivatives Product Safety
420 with CNW — FDA Seeks More Data in Fight Against Delta-8 THC Products
Via CannabisNewsWire
Topics Cannabis Derivatives
Exposures Cannabis Derivatives Product Safety
Research Links Diets High in Fat to Chronic Pain
Via Investor Brand Network
420 with CNW — DOJ Requests Additional Time in Cannabis Consumption Sites Case
Via Investor Brand Network
Topics Cannabis Government Law Enforcement
Exposures Cannabis Financial Legal
420 with CNW — DOJ Requests Additional Time in Cannabis Consumption Sites Case
Via CannabisNewsWire
Topics Cannabis Government Law Enforcement
Exposures Cannabis Financial Legal
420 with CNW — Colorado Regulators Allow Medical Cannabis to Be Recategorized as Recreational Marijuana
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Colorado Regulators Allow Medical Cannabis to Be Recategorized as Recreational Marijuana
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Existing Drug May Alleviate Side Effects of Cancer Treatment
Via Investor Brand Network
420 with CNW — New Study Finds Medical Cannabis Legalization Reduces Use of Opioids by Cancer Patients
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — New Study Finds Medical Cannabis Legalization Reduces Use of Opioids by Cancer Patients
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Commences Trial Evaluating IGC-AD1 for the Treatment of Alzheimer’s-Related Symptoms
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) to Present at RHK 2022 Disruptive Growth Conference
Via Investor Brand Network
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
India Globalization Capital, Inc. (AMEX:IGC) has begun “A phase 2, multi-center, double-blind, randomized, placebo-controlled, trial of the safety and efficacy of IGC-AD1 on agitation in participants... 
Via Benzinga
IGC Commences Phase 2 Clinical Trials Evaluating Drug Candidate IGC-AD1 for the Treatment of Agitation in Dementia From Alzheimer’s Disease
From India Globalization Capital, Inc.
Via Business Wire
InvestorNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Numbers for Q2
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
India Globalization Capital Inc. (NYSE American: IGC) Is ‘One to Watch’
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
India Globalization Capital, Inc. (AMEX:IGC) reported its second fiscal quarter 2023 financial results, revealing revenue of $202,000, a 261% increase compared to $56,000 in the same quarter of 2022. 
Via Benzinga
IGC Reports Financial Results for Second Fiscal Quarter Ended Sept. 30, 2022
From India Globalization Capital, Inc.
Via Business Wire
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.